• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying

    3/1/24 8:48:40 AM ET
    $AMRK
    $DAR
    $PRGO
    $TTSH
    Other Specialty Stores
    Industrials
    Packaged Foods
    Consumer Staples
    Get the next $AMRK alert in real time by email

    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Perrigo

    • The Trade: Perrigo Company plc (NYSE:PRGO) CEO Patrick Lockwood-Taylor acquired a total of 9,500 shares an average price of $26.54. To acquire these shares, it cost around $252,168.
    • What’s Happening: On Feb. 27, Perrigo reported fourth-quarter 2023 net sales of $1.16 billion, up 0.1% Y/Y, slightly below the consensus of $1.18 billion.
    • What Perrigo Does: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care.

    A-Mark Precious Metals

    • The Trade: A-Mark Precious Metals, Inc. (NASDAQ:AMRK) Director Jess M Ravich acquired a total of 20,000 shares at an average price of $25.63. To acquire these shares, it cost around $512,536.
    • What’s Happening: On Feb. 6, A-Mark Precious Metals reported worse-than-expected second-quarter financial results.
    • What A-Mark Precious Metals Does: A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum and palladium bullion and related products in the form of bars, wafers, coins, and grains.

    Don’t forget to check out our premarket coverage here

    Darling Ingredients

    • The Trade: Darling Ingredients Inc. (NYSE:DAR) Director Kurt Stoffel bought a total of 8,000 shares at an average price of $41.62. To acquire these shares, it cost around $332,960.
    • What’s Happening: On Feb. 27, Darling Ingredients posted downbeat quarterly results.
    • What Darling Ingredients Does: Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries.

    Tile Shop Holdings

    • The Trade: Tile Shop Holdings, Inc. (NASDAQ:TTSH) 10% owner Pleasant Lake Onshore Feeder Fund LP bought a total of 282,629 shares at an average price of $6.92. The insider spent around $1.96 million to buy those shares.
    • What’s Happening: On Feb. 29, Tile Shop Holdings reported a fourth-quarter fiscal 2023 sales decline of 3.4% year-over-year, to $84.46 million, missing the consensus of $91.61 million.
    • What Tile Shop Holdings Does: Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States.

     

    Check This Out: Investor Optimism Improves Following PCE Report; Nasdaq Surges To Record High

    Get the next $AMRK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRK
    $DAR
    $PRGO
    $TTSH

    CompanyDatePrice TargetRatingAnalyst
    Darling Ingredients Inc.
    $DAR
    2/13/2026$45.00 → $58.00Buy
    TD Cowen
    Darling Ingredients Inc.
    $DAR
    2/2/2026$62.00Neutral → Outperform
    Robert W. Baird
    Darling Ingredients Inc.
    $DAR
    12/2/2025$34.00 → $45.00Hold → Buy
    TD Cowen
    Perrigo Company plc
    $PRGO
    11/6/2025$20.00Overweight → Neutral
    Analyst
    Darling Ingredients Inc.
    $DAR
    10/8/2025$45.00Buy
    BofA Securities
    Darling Ingredients Inc.
    $DAR
    8/20/2025$43.00Overweight
    Analyst
    Darling Ingredients Inc.
    $DAR
    7/25/2025$36.00Outperform → Neutral
    Robert W. Baird
    Darling Ingredients Inc.
    $DAR
    4/25/2025$37.00 → $34.00Hold
    TD Cowen
    More analyst ratings

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parker Geoffrey M. bought $106,350 worth of Ordinary Shares (7,500 units at $14.18) (SEC Form 4)

    4 - PERRIGO Co plc (0001585364) (Issuer)

    11/14/25 10:45:37 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP and CSO Lennox Abigail bought $28,125 worth of Ordinary Shares (1,255 units at $22.41) (SEC Form 4)

    4 - PERRIGO Co plc (0001585364) (Issuer)

    9/10/25 4:19:48 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel & Sec. Atkinson Charles bought $23,200 worth of Ordinary Shares (1,000 units at $23.20) (SEC Form 4)

    4 - PERRIGO Co plc (0001585364) (Issuer)

    9/9/25 3:47:36 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Parker Geoffrey M.

    4 - PERRIGO Co plc (0001585364) (Issuer)

    3/17/26 12:49:03 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Alford Bradley A

    4 - PERRIGO Co plc (0001585364) (Issuer)

    3/17/26 12:30:10 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Darling Ingredients Inc.

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    3/10/26 5:30:49 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Perrigo to Present at the UBS Global Consumer and Retail Conference

    DUBLIN, Ireland, March 3, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor is scheduled to present at the UBS Global Consumer and Retail Conference, on Wednesday, March 11th at 11:00 AM EDT. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.About Perrigo Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness s

    3/3/26 4:30:00 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations

    Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook RangeAdvanced '3-S Plan' with Perrigo Store Brand OTC and Key Brands Gaining Share1,2 in 2025, Despite Soft Category ConsumptionLaunching New Operational Enhancement Program - Expected to Deliver Pre-Tax Annualized Savings of $80 million to $100 millionTransitioning to New Reporting Segments Beginning Q1 2026, Aligned to Commercial Operating ModelIssues FY2026 'All In' Outlook; Introduces FY2026 'CORE' Outlook, which Excludes Infant Formula and Previously Announced DivestituresFourth Quarter 2025 YoY Highlights:Net Sales: $1.11 billion, -2.5% year-over-year as favorable FX +2.3% was more than offset by organic net sales -4.5% and t

    2/26/26 6:31:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Darling Ingredients Director Gary Mize to retire from Board at Annual Meeting; Robert Aspell elected to Board of Directors

    Darling Ingredients Inc. (NYSE:DAR), today announced that long-time board member Gary Mize has informed the board that he plans to retire, effective at the company's 2026 Annual Meeting of Stockholders. Mr. Mize will remain a director and maintain his committee membership through the 2026 Annual Meeting. Additionally, the company announced that Robert Aspell has been elected to the board as an independent director, effective immediately. Mr. Aspell will serve on the board's Audit Committee. Mr. Mize joined the Darling Ingredients Board of Directors in 2016 and has served as its Lead Director since 2021. His career includes tenure as a partner and business owner at MR & Associates, a con

    2/25/26 4:45:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $AMRK
    $DAR
    $PRGO
    $TTSH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 13, 2023 - FDA Approves First Nonprescription Daily Oral Contraceptive

    For Immediate Release: July 13, 2023 Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stor

    7/13/23 8:32:15 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRK
    $DAR
    $PRGO
    $TTSH
    SEC Filings

    View All

    Perrigo Company plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - PERRIGO Co plc (0001585364) (Filer)

    3/23/26 4:18:48 PM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Perrigo Company plc

    DEFA14A - PERRIGO Co plc (0001585364) (Filer)

    3/20/26 11:34:30 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Perrigo Company plc

    DEF 14A - PERRIGO Co plc (0001585364) (Filer)

    3/20/26 11:33:07 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Darling Ingredients with a new price target

    TD Cowen reiterated coverage of Darling Ingredients with a rating of Buy and set a new price target of $58.00 from $45.00 previously

    2/13/26 8:02:23 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Darling Ingredients from Neutral to Outperform and set a new price target of $62.00

    2/2/26 6:46:46 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients upgraded by TD Cowen with a new price target

    TD Cowen upgraded Darling Ingredients from Hold to Buy and set a new price target of $45.00 from $34.00 previously

    12/2/25 8:02:38 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Perrigo Announces Global Operations and Supply Chain Leadership Transition

    Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer DUBLIN, June 4, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Matt Winterman as Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, effective June 23, 2025. Mr. Winterman succeeds Ron Janish, who will retire from the Company on September 30, 2025, following a distinguished career at Perrigo spanning more than two decades. Both executives will closely work together to ensure a smooth tran

    6/4/25 8:30:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    A-Mark Precious Metals Appoints Cary Dickson as Chief Financial Officer Effective July 1, 2025

    EL SEGUNDO, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ:AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has appointed Cary Dickson as Chief Financial Officer effective July 1, 2025. Mr. Dickson, who previously served as the company's CFO from November 2015 through September 2019, will re-join A-Mark on May 2, 2025 as its Executive Vice President, and will assume the role of CFO upon the departure of current CFO Kathleen Simpson-Taylor, who has informed the company of her decision to retire as of the end of the current fiscal year. A-Mark Chief Executive Officer Greg Roberts stated, "I am e

    4/14/25 8:00:00 AM ET
    $AMRK
    Other Specialty Stores
    Industrials

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tile Shop Holdings Inc.

    SC 13G/A - TILE SHOP HOLDINGS, INC. (0001552800) (Subject)

    11/14/24 4:08:07 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by A-Mark Precious Metals Inc.

    SC 13G/A - A-Mark Precious Metals, Inc. (0001591588) (Subject)

    11/12/24 12:12:50 PM ET
    $AMRK
    Other Specialty Stores
    Industrials

    SEC Form SC 13G filed by A-Mark Precious Metals Inc.

    SC 13G - A-Mark Precious Metals, Inc. (0001591588) (Subject)

    11/12/24 9:50:12 AM ET
    $AMRK
    Other Specialty Stores
    Industrials

    $AMRK
    $DAR
    $PRGO
    $TTSH
    Financials

    Live finance-specific insights

    View All

    Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations

    Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook RangeAdvanced '3-S Plan' with Perrigo Store Brand OTC and Key Brands Gaining Share1,2 in 2025, Despite Soft Category ConsumptionLaunching New Operational Enhancement Program - Expected to Deliver Pre-Tax Annualized Savings of $80 million to $100 millionTransitioning to New Reporting Segments Beginning Q1 2026, Aligned to Commercial Operating ModelIssues FY2026 'All In' Outlook; Introduces FY2026 'CORE' Outlook, which Excludes Infant Formula and Previously Announced DivestituresFourth Quarter 2025 YoY Highlights:Net Sales: $1.11 billion, -2.5% year-over-year as favorable FX +2.3% was more than offset by organic net sales -4.5% and t

    2/26/26 6:31:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Perrigo Announces Quarterly Dividend

    DUBLIN, Feb. 19, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of consumer products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on March 24, 2026, to shareholders of record on March 2, 2026. About Perrigo Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pione

    2/19/26 9:00:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

    DUBLIN, Feb. 13, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider of consumer health products, today announced that it plans to issue its fourth quarter and fiscal year 2025 financial results on Thursday, February 26th, 2026, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 52719.

    2/13/26 8:30:00 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care